Development of guidelines for the preparation and administration of ribavirin
Related Experiment Video
Updated: Oct 24, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
1St. Vincent Hospital and Health Care Center, Indianapolis, IN 46260.
Abstract:
Due to numerous inquiries from neonatal professional staff members regarding the potential teratogenic effects of ribavirin, the decision was made to establish institutional guidelines for its safe administration and preparation. The neonatal pharmacist was asked to prepare guidelines from available information in the literature and other institutions' practice standards.
Related Concept Videos
Viral Hepatitis I: Introduction
Antiviral Nucleoside Inhibitors
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Inhibitors Of Virion Release
Hepatitis
